Cor triatriatum surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

In cor triatriatum, adminstration of effective surgical therapy in a timely manner can greatly impact the patient’s prognosis. Considerations must made to evaluate to utilize the most appropriate surgical approach, right atrial or left atrial.

Surgical Therapy

The role of percutaneous balloon dilation in managing this condition remains to be determined.
It can be treated surgically by removing the membrane dividing the atrium.

Left atrial approach

Better if the patient is older, and defect is larger
Excise the obstructing diaphragm
Enlarge the left atrium as needed and close the interatrial connection

Right atrial approach

Better if the patient is younger, and defect is smaller

Locate the diaphragm through the ASD
Excise the obstructing diaphragm
Close the ASD

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[1]

2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines^[1]

Therapeutic Recommendations for Cor Triatriatum

Class I
1. In patients presenting with acute chest pain and suspected ACS, clinical decision pathways (CDPs) should categorize patients into low-, intermediate-, and high-risk strata to facilitate disposition and subsequent diagnostic evaluation.(Level of Evidence: B-NR)

References

↑ Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.

Template:WikiDoc Sources

[pmid30121240-1] Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.

[1]